You cannot legally sell medical devices in Europe without EUDAMED registration after May 28, 2026. While the system currently operates on a voluntary basis, the European Commission has confirmed that EUDAMED’s four validated modules will become mandatory following a six-month transition period. This means manufacturers must complete both actor and UDI device registrations to maintain EU market access.
What Exactly Is EUDAMED and Why Does It Matter for Medical Device Sales?
EUDAMED is the European Database on Medical Devices, a centralized digital system that tracks medical devices, IVDs, and organizations throughout the European market. It serves as the backbone of the Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR) compliance framework.
The database creates transparency across the entire medical device lifecycle through several key functions:
- Healthcare professional verification – Medical professionals can access verified device information to make informed treatment decisions
- Regulatory authority monitoring – Competent authorities track post-market surveillance data and coordinate safety responses across member states
- Patient safety access – Patients gain direct access to safety information and device performance data
- Unified compliance framework – The system replaces fragmented national databases with standardized EU-wide tracking
This comprehensive approach transforms medical device oversight from a collection of separate national systems into a coordinated European framework that enhances safety monitoring and regulatory efficiency. EUDAMED matters for medical device sales because it directly controls market access across all 27 EU member states, making registration essential for demonstrating regulatory compliance and maintaining commercial operations.
The European Commission confirmed on November 27, 2025, that four EUDAMED modules are fully functional: Actors Registration, UDI Database, Notified Bodies Certificates, and Market Surveillance. This confirmation triggered the mandatory implementation timeline that affects all medical device manufacturers.
Can You Legally Sell Medical Devices in Europe Without EUDAMED Registration?
No, you cannot legally sell medical devices in Europe without EUDAMED registration after May 28, 2026. The mandatory use period begins following the six-month transition period that started with the European Commission’s implementing decision published on November 27, 2025.
Currently, EUDAMED operates on a voluntary basis, allowing manufacturers to familiarize themselves with the system. However, this voluntary period ends definitively on May 28, 2026. From that date forward, two critical registration requirements become mandatory:
- Actor registration completion – Companies must register as economic operators and obtain a Single Registration Number (SRN) before any device registration can begin
- Device UDI registration – All products first placed on the EU market after the deadline require prior EUDAMED registration with Basic UDI-DI information, risk classification, and structured device data
- Competent authority approval – Both registrations require review and approval from designated authorities, which can take varying amounts of time based on workload
- Ongoing maintenance obligations – Registered information must be kept current throughout the device lifecycle, including safety updates and recalls
These requirements create a clear compliance framework where non-registration directly blocks market access, regardless of CE marking status or other regulatory approvals. The system ensures that only properly tracked and monitored devices can reach European patients and healthcare providers.
What Are Your Options if EUDAMED Registration Seems Overwhelming?
You can work with regulatory specialists, authorized representatives, or phased implementation strategies to manage EUDAMED compliance without overwhelming your internal resources. Many manufacturers successfully navigate registration by choosing the right support structure and timeline.
Several practical approaches can simplify the registration process:
- European Authorized Representatives (EARs) – Handle actor registration, manage competent authority approvals, and coordinate ongoing compliance on your behalf
- Phased implementation strategies – Start with actor registration well before deadlines, then systematically address UDI registrations for priority devices
- Technology solutions – Cloud-based platforms automate data transfer, manage XML bulk uploads, and integrate with existing quality management systems
- Portfolio consolidation – Review and streamline device portfolios, align master data, and ensure consistent UDI assignment before registration begins
- Sandbox testing – Use EUDAMED’s test environment to validate approaches and identify issues before live submissions
These options provide flexibility for manufacturers with different resource levels and technical capabilities. The key is selecting an approach that matches your organization’s capacity while ensuring compliance deadlines are met. Whether through external support or internal development, successful EUDAMED registration requires systematic preparation and clear execution timelines.
How Do You Actually Get Started with EUDAMED Registration?
Begin with actor registration immediately, gather device master data, and choose your submission method based on portfolio size and technical capabilities. Early preparation prevents deadline bottlenecks and ensures smoother approval processes.
The registration process follows a structured sequence with specific requirements at each stage:
- Actor registration preparation – Compile legal entity information, contact details, and role classifications while coordinating with authorized representatives for non-EU manufacturers
- Device master data consolidation – Gather Basic UDI-DI codes, EMDN classifications, risk classifications, and detailed device characteristics across all systems
- Submission method selection – Choose manual entry for small portfolios, XML bulk uploads for larger collections, or M2M integration for sophisticated operations
- Sandbox environment testing – Validate technical compatibility, identify schema issues, and test workflows before live submissions
- Quality management integration – Establish clear ownership, change management procedures, and update workflows for ongoing maintenance
This systematic approach addresses both immediate registration needs and long-term compliance maintenance. Starting early allows time for corrections, reduces approval bottlenecks, and ensures your organization can adapt to any unexpected technical or regulatory requirements that emerge during the process.
How MedEnvoy Global Helps with EUDAMED Registration
MedEnvoy Global provides comprehensive EUDAMED registration solutions that eliminate compliance barriers and accelerate market access for medical device manufacturers. Our specialized approach combines technical expertise with regulatory knowledge to streamline the entire registration process.
- Complete actor registration management – We handle Single Registration Number (SRN) acquisition, competent authority coordination, and authorized representative services for non-EU manufacturers
- Automated UDI database submissions – Our cloud-based platform manages bulk XML uploads, validates device data, and ensures consistent Basic UDI-DI registration across your entire portfolio
- Ongoing compliance maintenance – We provide continuous monitoring, update management, and post-market surveillance coordination to keep your registrations current
- Quality management integration – Our systems seamlessly connect with existing QMS platforms, ensuring data consistency and streamlined change control processes
Don’t let EUDAMED registration deadlines compromise your European market access. Contact MedEnvoy Global today to discover how our proven registration solutions can secure your compliance while you focus on innovation and growth.